Eribulin In Liposarcoma: Added Benefit Not Proven

Eribulin In Liposarcoma: Added Benefit Not Proven

Eribulin (trade name: Halaven) has been approved since May 2016 for the treatment of adults with advanced liposarcoma. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined…